Core Insights - The article provides an overview of the performance of various mutual funds, highlighting the top-performing and bottom-performing funds based on their net asset values and percentage changes [2][3]. Fund Performance Summary Top 10 Funds by Net Value Growth - The top-performing funds include: 1. Green Steady Value Mixed A: 0.6422, +5.23% 2. Green Steady Value Mixed C: 0.6294, +5.22% 3. Founder Fubon Core Advantage Mixed A: 1.2438, +4.86% 4. Founder Fubon Core Advantage Mixed C: 1.2287, +4.86% 5. China Merchants CSI Baijiu Index (LOF) C: 0.8017, +4.77% 6. China Merchants CSI Baijiu Index (LOF) A: 0.8051, +4.75% 7. Changxin Consumer Selected Quantitative Stock A: 1.0724, +4.75% 8. Changxin Consumer Selected Quantitative Stock C: 1.0541, +4.74% 9. Great Wall Quantitative Selected Stock A: 0.9294, +4.63% 10. Great Wall Quantitative Selected Stock C: 0.9076, +4.62% [2]. Bottom 10 Funds by Net Value Decline - The underperforming funds include: 1. Debon High-end Equipment Mixed A: 1.0344, -4.39% 2. Debon High-end Equipment Mixed C: 1.0328, -4.39% 3. Great Wall Emerging Industry C: 2.3570, -4.27% 4. Great Wall Emerging Industry A: 2.3880, -4.27% 5. Caitong Asset Management Advanced C: 1.7010, -4.22% 6. Caitong Asset Management Advanced A: 1.7083, -4.22% 7. Minsheng Jia Yin Front C: 1.0481, -4.17% 8. China Ocean Charm Long C: 3.2950, -3.96% 9. Founder Fubon Far C: 1.2067, -3.96% 10. Founder Fubon Far A: 1.2329, -3.95% [3]. Market Overview - The Shanghai Composite Index opened high but closed with a small gain, while the ChiNext Index experienced a high opening followed by a decline, ending with a small loss. The total trading volume reached 2.19 trillion, with 3,376 stocks rising and 1,957 falling [5]. - Leading sectors included hotel and catering, as well as liquor, both showing gains of over 3%, while the engineering machinery sector saw a decline of over 2% [5]. Fund Holdings Analysis Green Steady Value Mixed Fund - The fund has a high concentration in the liquor industry, with a holding concentration of 82.89%. Notable stocks include: - Gujing Gongjiu: +6.73% - Shanxi Fenjiu: +6.35% - Moutai: +2.02% - Wuliangye: +3.47% [6]. Debon High-end Equipment Fund - This fund has a lower concentration in its top holdings at 60.76%. Key stocks include: - Zhejiang Rongtai: -10.00% - Silver Wheel: -3.02% - Hanwei Technology: -5.17% [6].

Core Insights - Yao Yifan has resigned from his positions as fund manager for Changxin Consumer Select and Changxin Healthcare Mixed (LOF) funds [1][2] - Yao Yifan joined Changxin Fund Management in July 2015 and has held various roles including quantitative researcher and assistant fund manager [1] Fund Performance Summary - **Changxin Consumer Select Quantitative Stock A**: - Established on March 7, 2018 - Year-to-date return: -6.02% - Cumulative return: 3.30% - Cumulative net value: 1.0330 yuan [1] - **Changxin Consumer Select Quantitative Stock C**: - Established on August 12, 2021 - Year-to-date return: -6.17% - Cumulative return: -46.73% - Cumulative net value: 1.0174 yuan [1] - **Changxin Healthcare Mixed (LOF) A**: - Established on March 26, 2010 - Year-to-date return: 1.99% - Cumulative return: 95.04% - Cumulative net value: 1.7700 yuan [1] - **Changxin Healthcare Mixed (LOF) C**: - Established on August 12, 2021 - Year-to-date return: 1.76% - Cumulative return: -49.10% - Cumulative net value: 1.2120 yuan [1] Management Changes - Yao Yifan's departure is noted as a dismissal from his role as fund manager for both funds [2] - Jing Jie will continue to co-manage the funds alongside other fund managers [2]

Core Insights - The majority of ordinary stock funds in China have performed well in the first seven months of the year, with 92% of the 983 funds showing positive returns [1] - The top-performing fund, Huaan Medical Biotechnology, achieved a remarkable increase of over 105% [1] - The strong performance of these funds is largely attributed to their heavy investments in the pharmaceutical sector, with several stocks experiencing significant gains [2][3] Fund Performance - Huaan Medical Biotechnology Fund A and C led the performance with increases of 105.40% and 104.88% respectively, heavily investing in companies like Innovent Biologics and Stone Pharma [1] - Other notable funds include Jiashi Mutual Selection and Fortune Medical Innovation, which saw increases of 97.28% and 96.67% respectively, also focusing on pharmaceutical stocks [2] - Funds with over 80% growth include Ping An Medical Selected Stocks and Penghua Medical Technology Stocks, indicating a strong trend in the healthcare investment space [3] Underperforming Funds - Only seven funds experienced declines exceeding 10%, primarily in sectors like consumer goods, new energy, and technology [4] - The Minsheng Plus Silver Preferred Stock Fund saw a decline of 13.06%, with major holdings in companies like CATL and BYD [4] - Other funds with significant declines include Changxin Consumer Selected Quantitative Stocks and Beixin Ruifeng Preferred Growth, both heavily invested in the liquor sector [5]